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ABSTRACT 
Paroxysmal nocturnal haemoglobinuria (PNH) also known as ‘Marchiafava Micheli syn-
drome’ is a rare condition which can lead to both acute and chronic forms of renal failure 
through renal tubular haemosiderin deposition. A 45-year-old lady with underlying PNH, pre-
sented with complaints of fever, productive cough followed by dark coloured urine. Investiga-
tions revealed pancytopenia with a markedly raised creatinine from her baseline (from 
65 mmol/L to 385 mmol/L) consistent with acute kidney injury (AKI). Renal biopsy con-
firmed the diagnosis of haeme nephropathy. The renal impairment improved rapidly and nor-
malised over a period of 5 days with alkaline diuresis (AD). The patient did not require hae-
modialysis unlike most other reported cases of AKI secondary to haeme nephropathy in PNH. 
This is the second reported case of AKI in PNH which was successfully treated with AD 
alone emphasizing the role of AD as a promising therapeutic strategy in this condition. 
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INTRODUCTION 
Paroxysmal nocturnal haemoglobinuria 
(PNH) is an extremely rare acquired clonal 
disorder of hematopoiesis also termed as 
Marchiafava syndrome. PNH is a misnomer 
as the haemoglobinuria happens throughout 
the day. Haemolysis, thrombosis and bone 
marrow suppression are cardinal features of 
this condition (Enneking, 1928). Although 
infrequent, acute kidney injury is a serious 
and recognised complication. Patients usu-
ally present with renal impairment follow-
ing a bout of haemolysis. Acute renal fail-
ure is usually fully reversible with haemo-
dialysis but can occasionally be fatal 
(Nishimura et al., 2004). We hereby present 
a case report of acute kidney injury in PNH 
which was successfully treated with alka-
line diuresis (AD) alone.  
 
CASE REPORT 
A 45-year-old lady was diagnosed to 
have PNH in October 2007 based on histo-
ry, positive Ham’s test and immunopheno-
typing showing reduced CD 59 and CD 55 
expression. Since diagnosis, she had recur-
rent admissions due to pancytopenia. In the 
most recent admission, she presented with 
complaints of fever and productive cough 
preceding passing out dark-red coloured 
urine. The urine output was good with no 
other urinary symptoms.  
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Laboratory investigations showed pan-
cytopenia; haemoglobin of 5.9 g/dL, white 
cell count of 3.5 X 109/dL and platelet of 
104 X 10 9 dL. Her renal profile had always 
been normal. However, during this admis-
sion her creatinine was 385 mmol/L ( nor-
mal range 45-95 mmol/L) and the urea was 
23 mg/dL. The electrolytes and blood pH 
were normal. Urine FEME was positive for 
haemoglobin and negative for protein, ni-
trite and leucocytes. Ultrasound of the kid-
neys was normal with no evidence of renal 
vein thrombosis. Renal biopsy showed 
haeme pigment deposition in the distal con-
voluted tubules (Figure 1). Based on the 
above findings, the diagnosis of haeme 
nephropathy in paroxysmal nocturnal hae-
moglobinuria was made. The patient was 
treated with antibiotics for chest infection, 
transfused with packed cells and was given 
Danazol 200 mg bd. She was given intrave-
nous fluids 5 litres over 24 hours with in-
travenous furosemide 40 mg bd. Her urine 
was alkalinised with intravenous 1.4 % so-
dium bicarbonate at 50 mls per hour. The 
target level for her urine pH was more 
than 7.  
There was no indication for an urgent 
dialysis such as hyperkalemia, fluid over-
load or metabolic acidosis. We kept in mind 
haemodialysis as the definite next option 
should she not respond to the regimen de-
scribed above. Fortunately, after the initial 
48 hours of alkaline diuresis, her creatinine 
improved to 162 mmol/L. With such prom-
ising early results, we continued with the 
same treatment. Over the following 3 days, 
her creatinine rapidly normalised. She was 
discharged well with a normal kidney func-
tion after 7 days of hospital stay. 
 
DISCUSSION 
The earliest description of PNH was by 
Paul Strübing (1882) who described the 
case in a 29-year-old cartwright who pre-
sented with fatigue, abdominal pain, and 
severe nocturnal paroxysms of hemoglobi-
nuria. Later, Marchiafava and Micheli 
threw much light on the disorder and it was 
Enneking in 1925 who coined the term 
‘paroxysmal nocturnal haemoglobinuria’ 
(Enneking, 1928).  
 
 
 
Figure 1: Renal biopsy specimen with H & E stain showing distal convoluted tubules with  
haemosiderin deposition (arrows) under 40x magnification 
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Renal failure in PNH was first described 
in 1953. Over the years, renal involvement 
in PNH has become a well recognised po-
tentially serious complication. In PNH, the 
spectrum of kidney involvement ranges 
from the acute reversible kidney injury to 
chronic irreversible kidney disease. Renal 
failure is the cause of death in up to 18 % of 
patients. More than half of the patients tend 
to develop chronic kidney disease second-
ary to tubular haemosiderin deposition and 
microvascular thrombosis (Nishimura et al., 
2004).  
There are several mechanisms that may 
contribute to acute renal failure in PNH. 
The commonest mechanism proven by re-
nal biopsy findings of affected patients in 
the previous case reports was haeme 
nephropathy with acute tubular necrosis 
secondary to haemosiderin deposition from 
intravascular haemolysis (Table 1). Urinary 
tract infections, renal vein thrombosis and 
microvascular thrombosis have also been 
implicated. Renal failure is associated with 
poorer prognosis in PNH (Nishimura et al., 
2004).  
We believe that a good understanding of 
the involved pathogenesis is essential to 
plan the appropriate treatment strategies. In 
haeme nephropathy, when plasma hapto-
globin becomes saturated with haemoglo-
bin, free haemoglobin is filtered by the 
glomeruli followed by reabsorption in the 
proximal tubules (Nair et al., 2008). In the 
most recent case report, CD163 (a haemo-
globin scavenger receptor expressed in 
macrophages) and oxidative stress markers 
(NADPH-p22 phox and haeme oxygenase-
1) were thought to be involved (Ballarín et 
al., 2011).  
A thorough literature search with regard 
to past reported cases was done and the 
findings were tabulated (Table 1). In the 
past few decades, there were 13 of such re-
ported cases. It may be mentioned that the 
vast majority i.e up to 66.7 % of past re-
searchers and clinicians treated AKI in 
PNH with haemodialysis (Table 1). How-
ever, in the present case, we attempted AD. 
This case highlights the role of AD as a 
simple, non invasive yet effective and 
promising therapeutic approach to the 
treatment of AKI in PNH. This is the se-
cond reported case of AKI in PNH which 
was treated with the above method which is 
otherwise used for treating pigment 
nephropathy due to rhabdomyolysis and in 
certain types of drug poisoning such as sa-
licylate and phenobarbitone (Savege et al., 
1969; Tsai et al., 2007).  
Our rationale for choosing AD was 
based on the knowledge that AKI in both 
PNH and rhabdomyolysis share similar if 
not the same pathogenesis. It was therefore 
speculated that AD in PNH would yield 
comparable results with rhabdomyolysis. 
The renal outcome of this patient supported 
our hypothesis.  
AD involves intravenous administration 
of sodium bicarbonate (NaHCO3) with ei-
ther mannitol or loop diuretics. The alkaline 
pH of urine promotes the solubility of pig-
ments and limits the formation of casts and 
crystals, while impairing the degradation of 
haemoglobin into heme and free iron and 
the associated nephrotoxic effect. The aim 
of this mode of treatment is to reach a urine 
pH above 6.5 (Tsai et al., 2007). 
Diuresis increases the rate of flow with-
in the nephron which in turn reduces pig-
ment deposition in the tubules. But it is of 
crucial importance to ensure that intravas-
cular volume is adequate prior to admin-
istration of diuretics. The two frequently 
used diuretics in this setting are mannitol 
and furosemide. Mannitol is an osmolar di-
uretic agent that acts by improving renal 
perfusion, promoting the excretion of myo-
globin, heme, and iron and decreasing the 
oxidative stress in the tubular cells. As op-
posed to mannitol which acts on the proxi-
mal convoluted tubules, furosemide pre-
vents the accumulation of pigments in distal 
convoluted tubules. Compared to mannitol, 
furosemide causes more intense diuresis 
and has the disadvantage of lowering the 
urine pH (Tsai et al., 2007).  
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Table 1: Summary of reported cases of acute kidney injury in paroxysmal nocturnal haemoglobinuria 
 
Year Gender Age Renal biopsy  
findings 
Treatment Renal im-
pairment 
Author 
1982 Female 30 Not done Prednisolone 
0.5 mg/kg and 
haemodialysis 
Reversible Mijares et al., 
1984 
1984 Male 30 extensive deposition 
of haemosiderin in 
the proximal tubules 
haemodialysis reversible Al-Harbi et al., 
1998 
1987 Male 33 not done haemodialysis reversible Al-Harbi et al., 
1998 
1989 Female 57 deposition of hemo-
siderin in the proxi-
mal tubular cells 
haemodialysis reversible Kondo et al., 
1990 
1994 Female 59 interstitial edema, 
tubular necrosis, 
acellular tubular 
casts and tubular 
regeneration 
conservative 
management 
reversible Zeidman et al., 
1994 
2001 * * acute tubular necro-
sis (ATN) and he-
mosiderosis 
intravenous 
fluid and hae-
modialysis 
reversible Chow et al., 
2001 
2001 Female 70 acute tubular necro-
sis with considera-
ble hemosiderin 
deposition 
haemodialysis reversible Jose and Lynn, 
2001 
2006 Male 70 hemosiderin deposi-
tion in the proximal 
and distal tubules 
with denudation of 
tubular epithelium 
prednisolone 
1 mg/kg 
reversible Nair et al., 2008 
2007 Female 46 acute tubular necro-
sis, deposition of 
hemosiderin and 
positive urate stain 
in the proximal tubu-
lar cells 
haemodialysis reversible Chen et al., 2007 
2007 Female 30 hemosiderin depos-
its in the tubular 
cells, as well as tub-
ular necrosis and 
degeneration 
methyl- 
prednisolone 
reversible Tsai et al., 2007 
2007 Male 49 not done haemodialysis reversible Nair et al., 2008 
2009 Male 57 atrophy of renal tu-
bules, partial necro-
sis of epithelial cells, 
haemosiderin depo-
sition 
forced alkaline 
diuresis 
almost 
completely 
reversible 
Qi et al., 2011 
2011  
* 
 
* 
haemosiderin de-
posits in tubular 
cells. strong im-
munostaining of 
cd163 
 
* 
 
* 
Ballarin et al., 
2011 
 
* information not available 
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Since 1969, the merits of AD has been 
studied and experimented especially in in-
toxications (Savege et al., 1969). Many cli-
nicians in the past did not explore this 
method in PNH as there is still strong skep-
ticism with regard to its effectiveness in 
restoring normal kidney function. Whilst 
the use of AD is actually debatable, early 
renal recovery had been noted in some pa-
tients with rhabdomyolysis. Early initiation 
of this form of therapy predicted a more 
favourable outcome (Brown et al., 2004; 
Tsai et al., 2007).  
In conclusion, the authors believe that 
AD may be an effective stand-alone thera-
peutic option to consider in AKI secondary 
to haeme nephropathy in PNH,especially 
among stable patients. This recommenda-
tion, however, is still premature and re-
quires further supporting evidence. The rar-
ity of this condition makes it difficult for 
more research to be conducted in this area.  
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